Johnson & Johnson (JNJ)
206.51
+6.55
(+3.28%)
USD |
NYSE |
Dec 10, 16:00
206.72
+0.21
(+0.10%)
After-Hours: 20:00
Johnson & Johnson Market Cap: 497.54B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 169.78B |
| Gilead Sciences, Inc. | 150.58B |
| Eli Lilly & Co. | 888.93B |
| Regeneron Pharmaceuticals, Inc. | 76.34B |
| Protagonist Therapeutics, Inc. | 5.706B |
Market Cap Related Metrics
| PE Ratio | 19.93 |
| PS Ratio | 5.434 |
| PEG Ratio | 0.2796 |
| Price to Book Value | 6.276 |
| Price to Free Cash Flow | 24.47 |
| Price | 206.51 |
| Earnings Yield | 5.02% |
| PEGY Ratio | 0.2699 |
| Operating PE Ratio | 21.07 |
| Normalized PE Ratio | 24.23 |